The kinetics of SARS-CoV-2-specific IgM and IgG seroconversion using the Vidas SARS-CoV-2 IgM and Vidas SARS-CoV-2 IgG assays were also compared in hospitalized and nonhospitalized COVID-19 patients. This evidence concerns the gene CD40LG and COVID-19.